Alerts will be sent to your verified email
Verify Email
KOBO
|
Kobo Biotech
|
Hind Bio Science
|
Ganga Pharma.
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
-1.77 % | -24.99 % | 0.71 % |
|
5yr average Equity Multiplier
|
4.06 | 3.76 | 1.37 |
|
5yr Average Asset Turnover Ratio
|
0.54 | 0.25 | 0.31 |
|
5yr Avg Net Profit Margin
|
-3.79 % | -39.56 % | 1.72 % |
|
Price to Book
|
0.0 | 9.3 | 0.98 |
|
P/E
|
0.0 | 53.33 | 89.76 |
|
5yr Avg Cash Conversion Cycle
|
0.0 | 197.57 Days | 237.0 Days |
|
Inventory Days
|
89.28 Days | 0.0 | 165.67 Days |
|
Days Receivable
|
0.0 | 198.39 Days | 126.89 Days |
|
Days Payable
|
147.48 Days | 104.32 Days | 119.78 Days |
|
5yr Average Interest Coverage Ratio
|
0.99 | -32.49 | 1.32 |
|
5yr Avg ROCE
|
11.79 % | -14.28 % | 3.77 % |
|
5yr Avg Operating Profit Margin
|
8.83 % | -38.68 % | 0.19 % |
|
5 yr average Debt to Equity
|
1.62 | 2.68 | 0.28 |
|
5yr CAGR Net Profit
|
n/a | n/a | 31.95 % |
|
5yr Average Return on Assets
|
-0.89 % | -8.2 % | 0.53 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
44.95 % | 12.19 % | 50.91 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
0.0 | 0.0 | -15.8 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Kobo Biotech
|
Hind Bio Science
|
Ganga Pharma.
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|